1. |
谢冬, 姜格宁, 陈晓峰, 等. 肺硬化性血管瘤165例外科治疗. 中华外科杂志, 2012, 50(2):120-123.
|
2. |
Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma)of the lung. Cancer, 1956, 9(1):53-75.
|
3. |
林慧庆, 黄杰, 程邦昌, 等. 肺硬化性血管瘤的临床与病理特征. 中国胸心血管外科临床杂志, 2004, 11(3):235-236.
|
4. |
Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1):a new clue to its histogenesis. Am J Surg Pathol, 2000, 24(11):1531-1536.
|
5. |
孙宇, 周立新, 赵敏, 等. 肺硬化性血管瘤组织起源的探讨. 中 华病理学杂志, 2012, 41(4):239-242.
|
6. |
Lin XY, Zhang D, Zhang Y, et al. In pulmonary sclerosing hemangioma expression of β-catenin, Axin, and C-myc differs between the two cell types. Virchows Arch, 2012, 461(1):59-65.
|
7. |
Lin XY, Fan CF, Dong XJ, et al. Expression and significance of stem cell markers in pulmonary sclerosing haemangioma. Histopathology, 2012, 61(2):178-185.
|
8. |
张建强, 周晓军, 孟奎, 等. 肺硬化性血管瘤组织中甲状腺转录因子-1的表达及其组织起源的探讨. 中华病理学杂志, 2002(01):42-45.
|
9. |
Lei Y, Yong D, Jun-zhong R, et al. Treatment of 28 patients with sclerosing hemangioma (SH)of the lung. J Cardiothorac Surg, 2012, 7(1):34-37.
|
10. |
Wang QB, Chen YQ, Shen JJ, et al. Sixteen cases of pulmonary sclerosing haemangioma:CT findings are not definitive for preoperative diagnosis. Clin Radiol, 2011, 66(8):708-714.
|
11. |
崔永, 林昌锦, 龚民, 等. 肺硬化性血管瘤的外科治疗. 中国胸 心血管外科临床杂志, 2008, 15(4):299-300.
|
12. |
Kim BH, Bae YS, Kim SH, et al. Usefulness of Ki-67 (MIB-1)immunostaining in the diagnosis of pulmonary sclerosing hemangiomas. APMIS, 2013, 121(2):105-110.
|
13. |
薛仰群, 王丽霞, 白玮, 等. Ki-67与p53在肺硬化性血管瘤中的表达及其临床意义. 肿瘤研究与临床, 2011, 23(9):610-612.
|
14. |
齐凤杰, 张秀伟, 张永兴, 等. p53蛋白表达和基因突变在所谓肺硬化性血管瘤组织中的意义. 中国肺癌杂志, 2006, 9(2):147-151.
|
15. |
赵桂彬, 崔键, 张凯, 等. 电视胸腔镜手术在肺硬化性血管瘤诊断和治疗中的应用. 中国微创外科杂志, 2011, 11(9):829-831.
|
16. |
Bae YS, Ro JY, Shim HS, et al. Pulmonary sclerosing haemangioma with metastatic spread to stomach. Histopathology, 2012, 6(7):1162-1164.
|
17. |
冯飞跃, 程贵余, 高树庚, 等. 肺硬化性血管瘤的诊断和手术治疗. 中华医学杂志, 2012, 92(17):1190-1193.
|